<ѻýҕl>Obamacare Cut Racial Disparities in Cancer Careѻýҕl> Time to cancer treatment evens in blacks and whites with Medicaid expansion Jun 03, 2019
<ѻýҕl>Trials Back Earlier Use of Androgen Receptor Inhibitorsѻýҕl> Improved survival in metastatic hormone-sensitive prostate cancer Jun 03, 2019
<ѻýҕl>Add-On Metformin Disappoints in Metastatic CRPCѻýҕl> No meaningful clinical benefit when paired with docetaxel-prednisone in castration-resistant prostate cancer Jun 02, 2019
<ѻýҕl>POLO Will Change Practice in Pancreatic Cancerѻýҕl> "Huge step forward" for metastatic disease, says expert Jun 02, 2019
<ѻýҕl>Dramatic OS Boost With Kisqali in Young Breast Ca Patientsѻýҕl> 'First study to demonstrate improved survival for a targeted therapy' in advanced disease Jun 02, 2019
<ѻýҕl>Front-Line Keytruda: The New Standard in Gastric Ca Tx?ѻýҕl> Pembrolizumab leads to comparable survival outcomes versus chemo Jun 01, 2019
<ѻýҕl>Low-Dose Tx Wins in Older Gastroesophageal Ca Patientsѻýҕl> Overall survival maintained with gains in quality of life May 15, 2019
<ѻýҕl>Ditching Chemo Appears Viable in Frontline Follicular Lymphomaѻýҕl> PFS 'nearly identical' at 3 years with novel immunomodulatory combination Jun 06, 2018
<ѻýҕl>PFS Rises in Ovarian Ca with Repeat Bevacizumabѻýҕl> Magnitude of benefit similar to first-line therapy Jun 06, 2018
<ѻýҕl>Quick Intervention Improves Care in Geriatric Cancer Patientsѻýҕl> Randomized trial improved oncologist-patient communication Jun 06, 2018
<ѻýҕl>Less Morbidity, Lower Costs Tied to MIS in Cervical Cancerѻýҕl> But minimally invasive surgery also linked to decreased survival Jun 05, 2018
<ѻýҕl>IMPACT Trial: Support for Targeted Cancer Tx Approachesѻýҕl> Survival doubled with therapy matched to tumor genetics Jun 05, 2018
<ѻýҕl>Pancreatic Ca Gets 20-Month Survival Boostѻýҕl> Aggressive post-surgery chemo regimen touted as new standard of care Jun 05, 2018
<ѻýҕl>Pre-Surgical CRT May Boost Survival in Pancreatic Caѻýҕl> Further data needed to clarify best approach and who would benefit most Jun 04, 2018
<ѻýҕl>Many with Metastatic Kidney Cancer Can Skip Surgeryѻýҕl> Overall survival with single-agent sunitinib better than with resection Jun 04, 2018
<ѻýҕl>Hot Chemo Fails in Rare Cancerѻýҕl> HIPEC and surgery equals surgery alone in peritoneal carcinomatosis Jun 04, 2018
<ѻýҕl>Rare Childhood Cancer Gets First Tx Advance in 30 Yearsѻýҕl> But impact unclear for U.S. rhabdomyosarcoma patients Jun 04, 2018
<ѻýҕl>Keytruda Alone Bests Chemo in Advanced NSCLCѻýҕl> Monotherapy boosts survival in patients with low PD-L1, no EGFR or ALK alterations Jun 04, 2018
<ѻýҕl>Ivosidenib Induces Deep Remissions in IDH1-Mutant AMLѻýҕl> On strength of phase I data, drug appears headed for FDA approval Jun 03, 2018
<ѻýҕl>PI3K Inhibitor Has Mixed Results in Advanced Breast Cancerѻýҕl> Modest progression benefit, but substantial side effects, with taselisib Jun 03, 2018
<ѻýҕl>Women Get Less Aggressive Tx for Head and Neck Caѻýҕl> Registry data find that women are less likely to receive chemotherapy or radiation than men Jun 01, 2018
<ѻýҕl>Lung Cancer Screening Rates Disappointѻýҕl> Evidence shows benefit for high-risk smokers but few get tested May 17, 2018
<ѻýҕl>CBT Tops Acupuncture for Treating Insomnia in Cancer Survivorsѻýҕl> But both methods provide alternative to sleeping pills May 17, 2018
<ѻýҕl>Six Months of Trastuzumab Equal to 12 in Breast Caѻýҕl> Similar outcomes and less cardiotoxicity, but more research needed May 16, 2018
<ѻýҕl>Another CDK4/6 Inhibitor Boosts PFS in Breast Cancerѻýҕl> Abemaciclib-fulvestrant combo for advanced HR+/HER2- disease Jun 08, 2017
<ѻýҕl>No Survival Benefit with Node Dissection in Ovarian Caѻýҕl> Macroscopic complete resection drives outcomes Jun 07, 2017
<ѻýҕl>Two Anti-HER2 Drugs Slightly Better Than Oneѻýҕl> Patient selection key to addition of pertuzumab to trastuzumab Jun 07, 2017
<ѻýҕl>New Standard for ALK-Positive NSCLCѻýҕl> Dramatic PFS, CNS benefits with alectinib Jun 06, 2017
<ѻýҕl>Genomic Testing Helps Cancer Patients -- When Results are Usedѻýҕl> Also, liquid biopsy can ID drug-responsive tumors Jun 06, 2017
<ѻýҕl>Dacomitinib Sets PFS Record in Phase III NSCLC Trialѻýҕl> Next-gen EGFR inhibitor wins head-to-head battle with gefitinib, at least for efficacy Jun 06, 2017
<ѻýҕl>CAR T Cells Drive Outcomes in MMѻýҕl> Studies show promise for precision immunotherapy Jun 06, 2017
<ѻýҕl>Immunotherapy Shows Promise in Tough-to-Treat Mesotheliomaѻýҕl> Outcomes improved with nivolumab alone or with ipilimumab in pretreated patients Jun 05, 2017
<ѻýҕl>Advanced Ca Patients Benefit from Online Symptom Reportsѻýҕl> Patient-reported outcomes tied to increased survival Jun 05, 2017
<ѻýҕl>Trastuzumab Copycat Has Similar Efficacyѻýҕl> Phase III trial compared substances in early-stage breast cancer Jun 05, 2017
<ѻýҕl>Big Win for PARP Inhibitor in Breast Cancerѻýҕl> PFS boost for HER2-negative, BRCA-mutated disease Jun 05, 2017
<ѻýҕl>Short-Course RT Helps Retain Ability to Walk in Advanced Caѻýҕl> Preferable to multi-dose radiotherapy for spinal cord compression Jun 04, 2017
<ѻýҕl>Novel Agent Shows Antitumor Activity in TRK-Fusion Cancersѻýҕl> Tumor genetics define treatment approach in early-stage trials Jun 04, 2017
<ѻýҕl>Mixed Results with Novel Tx in Sarcomaѻýҕl> Aldodoxorubicin can't boost PFS, but promising in L-sarcomas Jun 03, 2017
<ѻýҕl>Abiraterone Combo: A New Care Standard in Prostate Cancer?ѻýҕl> Earlier treatment appears to improve survival in metastatic disease Jun 03, 2017
<ѻýҕl>Second Surgery Slows Recurrent Ovarian Cancerѻýҕl> But no survival gain seen in interim analysis of DESKTOP III Jun 03, 2017